Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Dextrose (D-glucose): Precision Tool for Tumor Immunometabol
2026-07-13
Explore how Dextrose (D-glucose) enables advanced research into tumor immunometabolism and hypoxic adaptation. This article uniquely connects metabolic reprogramming, assay optimization, and translational impact, grounded in the latest scientific insights.
-
Decoding Aneugenic Mechanisms: Molecular Profiling via Flow
2026-07-13
Bernacki et al. introduce a mechanistically tiered assay that distinguishes between tubulin destabilization, stabilization, and mitotic kinase inhibition as drivers of chemical-induced aneugenicity. Their flow cytometric workflow, validated with 27 reference compounds, enables robust molecular target classification relevant to genotoxicity and advanced antifungal research.
-
Dextrose (D-glucose): Powering Hypoxia and Immunometabolic A
2026-07-12
Dextrose (D-glucose) empowers researchers to dissect hypoxia-driven metabolic reprogramming and immune cell function with precision and reproducibility. This guide delivers actionable workflows, advanced troubleshooting, and data-backed enhancements tailored for cutting-edge glucose metabolism research.
-
Bestatin (Ubenimex): Decoding Aminopeptidase Signaling in Pl
2026-07-10
Explore the unique capabilities of Bestatin (Ubenimex) as a selective aminopeptidase inhibitor for advanced apoptosis assays and multidrug resistance research. This article uncovers novel applications in plant signaling and cancer workflows, with insights not found in typical inhibitor reviews.
-
HDAC3 Modulates Ferroptosis via NRF2–GPX4 in Colorectal Canc
2026-07-09
This study identifies histone deacetylase 3 (HDAC3) as a central epigenetic suppressor of ferroptosis in colorectal cancer, acting through the NRF2–GPX4 signaling axis. The findings provide mechanistic insights and highlight new therapeutic opportunities to sensitize tumors to ferroptosis-inducing treatments.
-
LAMP1 Regulates CXCL10-CXCR3 Axis in Macrophage Polarization
2026-07-09
This study uncovers how LAMP1 modulates macrophage fate via the CXCL10-CXCR3 axis, revealing that macrophage polarization outcomes depend on inflammatory context and LAMP1 expression. Importantly, CXCR3 antagonism with AMG 487 reverses polarization direction and attenuates acute lung injury, providing a mechanistic framework for targeted intervention in inflammation.
-
Hypoxia and Immunometabolism in Tumor Microenvironments
2026-07-08
This review dissects how hypoxia-driven metabolic reprogramming and immune cell adaptations shape the tumor microenvironment (TME), influencing tumor progression and immune evasion. The analysis provides mechanistic insights into the interplay between oxygen deprivation, glucose metabolism, and immunosuppressive dynamics, guiding the development of metabolism-based cancer therapies.
-
Hypoxia-Driven Immunometabolic Reprogramming in Tumor Microe
2026-07-08
This review synthesizes recent advances in understanding how hypoxia and immunometabolism interact to shape the tumor microenvironment (TME). By detailing mechanisms of metabolic reprogramming and immune evasion under hypoxic stress, it provides a mechanistic foundation for metabolism-based cancer therapies and highlights challenges for translational research.
-
Optimizing Cancer Cell Assays with Ganetespib (STA-9090)
2026-07-07
This article delivers scenario-driven, evidence-based guidance for leveraging Ganetespib (STA-9090, SKU A4385) in cell viability and cytotoxicity assays. It addresses common laboratory challenges—such as reproducibility, sensitivity, and vendor selection—using real-world Q&A, protocol tips, and literature-backed data. Researchers will find actionable best practices and reliable performance insights tailored to advanced cancer research workflows.
-
IL-1β/NF-κB Drives ACE2 in Macrophage SARS-CoV-2 Susceptibil
2026-07-07
Lee et al. reveal that IL-1β-driven NF-κB activation upregulates ACE2 expression in macrophages, enabling productive SARS-CoV-2 infection in a novel humanized ACE2 mouse model. This study provides mechanistic insight into inflammation-mediated viral entry and highlights nuanced differences in COVID-19 disease models with implications for host resilience research.
-
Ferrostatin-1 in Ferroptosis Assays: Workflows, Applications
2026-07-06
Ferrostatin-1 (Fer-1) stands at the forefront of mechanistic and applied ferroptosis inhibition, enabling reproducible oxidative lipid damage assays in cancer and neurodegeneration. This article delivers stepwise workflows, troubleshooting strategies, and context drawn from breakthrough redox modulation studies.
-
Artesunate as an AKT/mTOR Pathway Inhibitor in Cancer Models
2026-07-06
Artesunate, a high-purity artemisinin derivative from APExBIO, empowers cancer researchers to dissect pyroptosis and ferroptosis with quantitative precision. This article demystifies experimental workflows, troubleshooting, and the latest protocol enhancements for leveraging Artesunate in small cell lung carcinoma and esophageal squamous cell carcinoma research.
-
AI-Driven Discovery of Senolytics: Insights for Cancer Resea
2026-07-05
The referenced study pioneers the use of machine learning to identify novel senolytic compounds, advancing early-stage drug discovery with high efficiency and reduced costs. This approach demonstrates how integrating computational methods with biological screening can accelerate the development of therapies targeting cellular senescence, relevant to cancer and age-related diseases.
-
Sulfo-Cy3 Azide: Bioconjugation Reagent for Robust Click Che
2026-07-04
Sulfo-Cy3 azide stands out as a bioconjugation reagent for Click Chemistry, combining water solubility, reduced fluorescence quenching, and superior photostability. Its seamless integration in high-resolution neurodevelopmental studies and complex biomolecule labeling makes it a go-to solution for demanding fluorescence workflows.
-
Disodium Bicinchoninate: Redefining Water-Soluble Chelators
2026-07-03
Explore how Disodium bicinchoninate, a highly pure sodium [2,2'-biquinoline]-4,4'-dicarboxylate, enables advanced mitochondrial and inflammation studies. This article uncovers novel assay strategies and cross-domain insights beyond traditional molecular biology workflows.